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OBJECTIVES We sought to analyze the systemic effects of lower-limb exercise training (ET) on radial artery
endothelial function in patients with chronic heart failure (CHF).
BACKGROUND Local ET has the potential to improve local endothelial dysfunction in patients with CHF.
However, it remains unclear whether the systemic effects can be achieved by local ET.
METHODS Twenty-two male patients with CHF were prospectively randomized to either ET on a
bicycle ergometer (ET group, n 5 11; left ventricular ejection fraction [LVEF] 26 6 3%) or
an inactive control group (group C, n 5 11; LVEF 24 6 2%). At the beginning of the study
and after four weeks, endothelium-dependent and -independent vasodilation of the radial
artery was determined by intra-arterial infusion of acetylcholine (ACh—7.5, 15 and 30
mg/min) and nitroglycerin (0.2 mg/min). The mean internal diameter (ID) of the radial artery
was assessed using a high resolution ultrasound system (NIUS-02, Asulab Research
Laboratories, Neuchaˆtel, Switzerland) with a 10-MHz probe.
RESULTS After four weeks of ET, patients showed a significant increase in the baseline-corrected mean
ID in response to ACh (30 mg/min), from 33 6 10 to 127 6 25 mm (p , 0.001 vs. control
group at four weeks). In the control group, the response to ACh (30 mg/min) remained
unchanged. Endothelium-independent vasodilation was similar in both groups at the
beginning of the study and at four weeks. In the training group, increases in agonist-
mediated, endothelium-dependent vasodilation correlated to changes in functional work
capacity (r 5 0.63, p , 0.05).
CONCLUSIONS In patients with stable CHF, bicycle ergometer ET leads to a correction of endothelial
dysfunction of the upper extremity, indicating a systemic effect of local ET on endothelial
function. (J Am Coll Cardiol 2001;37:392–7) © 2001 by the American College of
Cardiology
The last decade has witnessed a paradigmatic shift from the
concept of chronic heart failure (CHF) as a “pump disorder”
to the growing understanding of heart failure as a systemic
neurohormonal disease, in which alterations of skeletal
muscle and increased systemic vasomotor tone with im-
paired peripheral perfusion contribute to a reduced exercise
capacity (1,2). Peripheral vasoconstriction in CHF has been
explained by neurohormonal changes like activation of the
sympathetic nervous system and the renin-angiotensin sys-
tem (3,4). In recent years, however, the major role of the
vascular endothelium in regulating local vasomotor tone has
been revealed (5,6). Endothelial cells regulate vascular
diameter by releasing nitric oxide (NO). Its production and
release are influenced by endocrine mediators like acetyl-
choline (ACh) (through muscarinic receptors); mechanical,
receptor-independent stimuli (shear stress); and the avail-
ability of the NO precursor, L-arginine. Different cardio-
vascular diseases (i.e., arterial hypertension, coronary artery
disease, CHF) are associated with an attenuated vasodila-
tory response to ACh, as well as impaired flow-dependent
vasodilation (FDVD) (7,8).
Cell culture experiments have indicated that shear stress
induces an upregulation of the endothelial NO synthase
(eNOS) (9). In animal studies, regular physical exercise
training (ET) enhances endothelium-dependent vasodila-
tion of conduit coronary arteries (10,11), suggesting that the
in vitro results may be relevant for endothelial function in
vivo. The positive effects of physical training on endothelial
dysfunction could also be documented in patients with
CHF. Local training interventions like handgrip exercise
(12–14) or bicycle ergometer training improve local flow-
dependent, endothelium-mediated vasodilation (15). How-
ever, these studies demonstrated only local effects of physical
ET on endothelial dysfunction of the trained extremity.
It has been a matter of continuing debate whether there
is a critical proportion of the whole body muscle mass that
has to be trained to achieve systemic effects on endothelial
function. Recently, it has been shown that 10 weeks of
lower-limb endurance training in healthy subjects with
normal endothelial function have systemic effects on
agonist-mediated, endothelium-dependent vasodilation (16).
It remains unclear, however, whether the systemic endo-
thelial effects can also be achieved by local ET in patients
with CHF, whose endothelial function is severely compro-
mised. Therefore, the objective of the present study was to
investigate whether lower-limb ET in patients with CHF
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has the potential to correct endothelial dysfunction of the
upper extremity, indicating systemic rather than local
changes of vascular function.
METHODS
Subjects. Twenty-two male patients age #70 years with
CHF due to dilated cardiomyopathy or ischemic heart
disease were studied. The diagnosis of heart disease was
based on cardiac catheterization. Left ventricular ejection
fraction (LVEF) was ,40%, as assessed by left ventriculo-
graphy. All patients were in stable clinical condition for
three months before enrollment and had clinical, radiologic
and echocardiographic signs of CHF (New York Heart
Association [NYHA] functional class II/III). At baseline, a
symptom-free exercise capacity of $25 W on bicycle er-
gometry was required.
Exclusion criteria included any conditions potentially
affecting endothelial function, such as arterial hypertension
(.160/90 mm Hg), hypercholesterolemia (total cholesterol
.6.0 mmol/liter), diabetes mellitus (fasting glucose .6.5
mmol/liter) and current smoking. Patients with heart failure
due to valvular heart disease were also excluded from the
study.
Study protocol. The study was approved by the Ethics
Committee of the University of Leipzig, and written,
informed consent was obtained from all patients.
At baseline, all patients performed a symptom-limited,
maximal ET on a calibrated, electronically braked bicycle in
an upright position. Work load was increased by 25 W every
3 min beginning at 25 W. Respiratory gas exchange was
determined continuously throughout the ET, as previously
described (15,17). Oxygen consumption was determined at
a maximal work load and at the ventilatory threshold. The
ventilatory threshold was defined as the oxygen uptake
before the systematic increase in the ventilatory equivalent
for oxygen, without a concomitant increase in the ventila-
tory equivalent for carbon dioxide (18).
One day after the maximal ET, endothelial function was
studied in the fasting state in a quiet and temperature- and
humidity-controlled room. All cardiovascular medications
were withheld for .24 h before assessment of endothelium-
dependent vasodilation.
Randomization. After baseline measurements, patients
were randomized to either a training or control group.
The patients assigned to the training program stayed in
the hospital for the period of the study. They exercised 6
times/day for 10 min on a bicycle ergometer under close
supervision, at 70% peak oxygen consumption. The patients
in the control group received their previous medications,
continued their sedentary life-style and were supervised by
their private physician.
High precision ultrasound and determination of arterial
diameter. For intra-arterial infusion of ACh and nitroglyc-
erin (NTG), a 20-gauge catheter was placed into the
brachial artery. Vessel diameter was measured as previously
described (14). In brief, after a rest period of 20 min in the
supine position, the internal diameter (ID) of the radial
artery was determined using a high precision A-mode
tracking ultrasound system, which permits measurement of
the vessel diameter with a precision of 62 mm (NIUS-02,
Asulab Research Laboratories, Neuchaˆtel, Switzerland). A
10-MHz transducer was positioned perpendicular to the
radial artery about 5 cm proximal to the wrist, without direct
skin contact. Blood flow velocity was recorded simulta-
neously using an 8-MHz Doppler probe (Doptek 2003,
Deltex France SA, Montpellier, France). Blood flow (ml/
min) was calculated as the average peak velocity 3 cross-
sectional area.
Intra-arterial infusions. Baseline measurements of the
arterial diameter were performed by infusing a 5% glucose
solution (Glucosteril 5%, Pharmacia, Erlangen, Germany)
at a constant rate of 1 ml/min for 5 min. Endothelium-
dependent vasodilation was assessed using ACh (Miochol
Ciba-Vision, Grossostheim, Germany) in increasing doses:
7.5, 15 and 30 mg/min were administered at a flow rate of
1 ml/min for 5 min at each concentration step.
For determination of FDVD, the brachial artery was
occluded by inflating the blood pressure (BP) cuff to
50 mm Hg above the systolic BP for 5 min. The ID of the
radial artery was recorded continuously for 2 min in 10-s
intervals after deflation of the occlusion cuff. The maximal
ID was recorded as a measure of FDVD.
Endothelium-independent vasodilation was determined
using NTG (Glyceroltrinitrat, Schwarz Pharma, Monheim,
Germany) at a dose of 0.2 mg/min and a flow rate of
1 ml/min. Between each intervention, the infusions were
stopped for 2 min to allow the radial artery diameter to
return to baseline values.
Statistical analysis. All data are expressed as the mean
value 6 SEM. The data were tested for normal distribution
using the Kolmogorov-Smirnov test, and for homogeneity
of variances using Levene’s test.
Absolute values, baseline-corrected IDs (difference be-
tween ID during infusion of the respective agonist and ID
during glucose infusion) and percent changes from baseline
were used for statistical analyses. Both intragroup and
intergroup comparisons were made using two-way repeated
Abbreviations and Acronyms
ACh 5 acetylcholine
BP 5 blood pressure
CHF 5 chronic heart failure
eNOS 5 endothelial nitric oxide synthase
ET 5 exercise training
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measures analysis of variance (ANOVA), followed by the
Tukey post hoc test. For the ANOVA procedure, both the
results of the test for the interaction between group and time
and the results of the Tukey post hoc test are reported. In
case of non-normal distribution, intragroup comparisons
were performed using the Wilcoxon signed-rank test; inter-
group comparisons were done using the Mann-Whitney U
test.
The relation between changes in endothelium-dependent
vasodilation and increases in peak oxygen consumption was
assessed by linear regression analysis. A p value ,0.05 was
considered statistically significant.
RESULTS
Patient characteristics. At baseline, patients in the train-
ing and control groups did not differ significantly in terms of
age, etiology of heart failure, NYHA functional class,
LVEF or left ventricular end-diastolic diameter. They had
similar values for blood glucose, total cholesterol and sys-
tolic and diastolic arterial pressure (Table 1).
Medical treatment. All patients were on angiotensin-
converting enzyme inhibitors, 73% were on diuretics, 54%
were on digoxin and 59% were on beta-blockers. Medical
therapy did not differ significantly between the two groups.
Drug treatment was not changed in any patient between at
least four weeks before enrollment and study termination
(Table 2).
Baseline measurements. At the beginning of the study, a
slight but significant difference in vessel diameter between
the training and control groups was noted during glucose
infusion: training group 3.42 6 0.12 mm versus control
group 2.99 6 0.13 mm (p , 0.05). However, patients in the
training and control groups had similar responses to ACh,
NTG and flow (Table 3), as assessed by the percent change
in radial artery diameter. There were no significant differ-
ences in oxygen uptake at the ventilatory threshold (11.5 6
0.9 vs. 11.5 6 0.9 ml/kg per min) or at peak exercise
(16.0 6 1.2 vs. 16.9 6 1.3 ml/kg per min) between training
and control groups.
Vasodilative responses to ACh. After four weeks of ET,
ACh-mediated, endothelium-dependent vasodilation in-
creased significantly from 33 6 10 to 127 6 25 mm (p ,
0.001 vs. control group at four weeks), from 114 6 31 to
290 6 47 mm (p , 0.001 vs. control group at four weeks)
and from 184 6 57 to 453 6 63 mm (p , 0.001 vs. control
group at four weeks) at 7.5, 15 and 30 mg/min of ACh,
respectively. In the control group, the response to ACh
remained virtually unchanged during the study period
(Fig. 1).
Vasodilative response to NTG. Bicycle ergometer train-
ing did not change the endothelium-independent vasodila-
tory capacity of the radial artery. In the training group,
infusion of NTG led to a comparable increase in the ID of
the radial artery at beginning and end of the study (594 6
47 vs. 602 6 56 mm, p 5 0.563). In parallel, the
endothelium-independent vasodilative capacity remained
unchanged in the control group.
Flow-dependent vasodilation. Four weeks of bicycle er-
gometer training were associated with a significant increase
in FDVD, from 374 6 57 to 570 6 76 mm (p , 0.01 vs.
control group at four weeks); in the control group, FDVD
remained essentially unchanged (344 6 20 mm at the
beginning of the study vs. 351 6 22 mm at four weeks).
Exercise capacity. Four weeks of aerobic ET led to a
significant increase in oxygen consumption at the ventilatory
threshold and at peak exercise, by 19 6 5% (from 11.5 6
0.9 to 13.4 6 0.9 ml/kg per min, p , 0.001 vs. beginning
of study; p 5 0.004 for interaction [ANOVA]) and by 21 6
2% (from 16.0 6 1.2 to 19.4 6 1.4 ml/kg per min, p ,
0.001 vs. beginning of study; p , 0.001 for interaction
[ANOVA]), respectively. In the control group, oxygen
consumption at the ventilatory threshold and at peak
exercise did not change between the beginning and end of
the study (11.5 6 0.8 vs. 11.3 6 0.8 ml/kg per min and
16.9 6 1.2 vs. 16.3 6 1.3 ml/kg per min). One patient in
the control group did not tolerate the mouth piece of the
ergospirometer during exercise; therefore, complete respira-
tory data are available in 10 control subjects.
Correlation between improvement of endothelial func-
tion and exercise capacity. Changes in agonist-mediated,
endothelium-dependent vasodilation (ACh [30 mg/min])
induced by ET were significantly correlated with changes in
peak oxygen consumption (r 5 0.63, p , 0.05) (Fig. 2).







ACE inhibitors 11 (100%) 11 (100%)
Diuretics 9 (82%) 7 (64%)
Digoxin 7 (64%) 5 (45%)
Beta-blockers 5 (45%) 8 (73%)
Data are presented as the number (%) of subjects.
ACE 5 angiotensin-converting enzyme.











NYHA functional class (II/III) 8/3 8/3
LVEDD (mm) 65 6 2 61 6 6
LVEF (%) 26 6 3 24 6 2
Blood glucose (mmol/liter) 5.6 6 0.2 5.3 6 0.3
Total cholesterol (mmol/liter) 5.2 6 0.2 4.6 6 0.3
RRdiast (mm Hg) 83 6 2 78 6 2
RRsyst (mm Hg) 128 6 3 123 6 5
Data are shown as the mean value 6 SEM or number of subjects.
CHF 5 chronic heart failure; DCM 5 dilated cardiomyopathy; IHD 5 ischemic
heart disease; LVEDD 5 left ventricular end-diastolic diameter; LVEF 5 left
ventricular ejection fraction; NYHA 5 New York Heart Association; RRdiast 5
diastolic arterial pressure; RRsyst 5 systolic arterial pressure.
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DISCUSSION
The present study may extend our current concept of the
effects of ET on vascular endothelial function in two
regards: 1) regular ET on the cycle ergometer has systemic
effects on endothelial function in patients with CHF; and
2) improvement in the endothelium-dependent vasodilative
capacity is correlated with an increase in exercise capacity
after four weeks of regular ET.
Effects of ET on endothelium-dependent vasodilation.
In patients with CHF, endothelium-dependent vasodilation
of peripheral vessels is impaired (7), possibly as a result of
impaired eNOS activity (8,15). Physical ET increases shear
stress by intermittently augmenting pulsatile flow along the
endothelium. During handgrip exercise, the increase in
pulsatile flow remains restricted to the forearm vessels. In
bicycle ergometer training, however, the trained muscle
mass exceeds the critical proportion necessary to achieve
systemic cardiovascular effects. Although one is inclined to
presume that the highest increase in blood flow—and thus
the most pronounced shear stress effects—will be in the
vasculature supplying the exercised muscles, the increases in
heart rate and BP amplitude during the training program
systemically increase pulsatile flow. In an independent
parallel study, a 10-week program of aerobic and anaerobic
ET in healthy young men led to a systemic enhancement of
endothelial function (16). The present study extends these
findings to pathologic states. To our knowledge, it is the
first to prove the systemic effects of lower-limb ET in
patients with CHF. Four weeks of bicycle ergometer ET at
a submaximal level led to a significant improvement of
endothelial function of the upper extremity. The vasodila-
tory response to ACh at the highest concentration increased
2.5-fold, whereas FDVD improved by 50%. Other factors
potentially influencing vascular endothelial function, such as
blood glucose, serum cholesterol levels and arterial BP,
remained unchanged during the study period. A possible
alternative hypothesis could be that ET induces changes in
circulating humoral factors, which, in turn, affect endothe-
lial function. However, no data on the short-term influences
of ET on catecholamines, for example, in patients with
CHF are available thus far.
Our results contrast with those of a previous study by
Demopoulos et al. (19), who failed to show any effect of
bicycle ergometer training on endothelial function of the
Table 3. Changes in Internal Diameter of the Radial Artery After Acetylcholine, Nitroglycerin and Reactive Hyperemia at the













Training group (n 5 11)
ACh 7.5 mg/min 33 6 10 127 6 25*† , 0.001 1.0 6 0.3 3.9 6 0.8*† , 0.001
ACh 15 mg/min 114 6 31 290 6 47*† , 0.001 3.6 6 1.0 8.8 6 1.7*† , 0.001
ACh 30 mg/min 184 6 57 453 6 63*† , 0.001 5.8 6 1.9 13.8 6 2.3*† , 0.001
NTG 0.2 mg/min 594 6 47 602 6 56 0.360 17.8 6 1.8 18.0 6 2.1 0.346
FDVD 374 6 57 570 6 76†‡ , 0.001 11.3 6 2.0 17.3 6 2.8† , 0.001
Control group (n 5 11)
ACh 7.5 mg/min 20 6 4 26 6 4 0.7 6 0.1 0.9 6 0.1
ACh 15 mg/min 86 6 9 95 6 11 3.0 6 0.4 3.2 6 0.4
ACh 30 mg/min 127 6 15 133 6 18 4.3 6 0.5 4.5 6 0.6
NTG 0.2 mg/min 600 6 104 517 6 31 21.2 6 4.9 17.4 6 1.2
FDVD 344 6 20 351 6 22 11.7 6 0.9 11.9 6 1.0
Results of the Tukey post hoc test: *p , 0.001 vs. control group at four weeks; †p , 0.001 vs. training group at beginning of study; ‡p , 0.01 vs. control group at four weeks.
In the analysis of variance (ANOVA) interaction column, the results (p values) of the ANOVA procedure for the interaction between group and time are reported. Data are shown
as the mean value 6 SEM. Values represent absolute changes and percent changes from baseline (infusion of 5% glucose).
ACh 5 acetylcholine; FDVD 5 flow-dependent vasodilation; ID 5 internal diameter; NTG 5 nitroglycerin.
Figure 1. Individual changes of the endothelium-dependent, vasodilative response to ACh at a dose of 30 mg/min at the beginning of the study and after
four weeks of ET (left panel) and in control subjects (right panel). The percent changes in ID, as compared with baseline diameter (5% glucose infusion),
are provided. *p , 0.001 vs. beginning of study. ##p , 0.001 vs. control group.
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untrained upper extremity. Several differences of the
present study may explain the divergent findings: 1) ET
was performed at a significantly lower intensity, which
may not have had the effects on BP amplitude necessary
to attain systemic effects; 2) the patients studied by
Demopoulos et al. (19) were in more advanced stages of
heart failure; and 3) their methodologic approach for
measuring endothelial function differed from that of our
study (forearm venous occlusion plethysmography vs.
high resolution ultrasound).
Correlation between endothelium-dependent vasodila-
tion and exercise capacity. In a previous study involving
patients with CHF, we found a correlation between changes
in endothelium-dependent vasodilation and changes in
functional work capacity (15). In accordance with this
observation, changes in endothelium-dependent vasodila-
tory capacity were related to changes in peak oxygen uptake
in the present study. The correlation between improvement
of endothelial vasodilatory function and functional work
capacity implies that by improving endothelial dysfunction,
exercised-induced peripheral perfusion is augmented,
which, in turn, leads to a higher exercise capacity.
Effects of ET on FDVD. Endothelial dysfunction in CHF
is not restricted only to agonist-mediated vasodilation; it
also affects FDVD during reactive hyperemia (12). During
reactive hyperemia, the maximal vasodilation occurs ;40 to
60 s after release of arterial occlusion (20). In animal as well
as in human studies, it could be shown that FDVD is
mediated partly by endothelium-derived NO (21–23). The
proportion of FDVD inhibited by NG-monomethyl
L-arginine (L-NMMA), an eNOS inhibitor, increases sig-
nificantly after ET in patients with CHF (12,15). These
results indicate an increased basal activity of eNOS after
ET, which may be indicative of eNOS upregulation after
training, as previously described in animal experiments
(9,10).
Because endothelial factors contribute substantially to
reactive hyperemia, we expected significant changes after
ET. Maximal FDVD was significantly enhanced after ET
by 54%.
Effects of ET on endothelium-independent vasodilation.
Like other cardiovascular diseases, CHF is associated with
increased oxidative stress. Reactive oxygen species, such as
superoxide anions (O2
2) rapidly scavenge NO, leading to an
accelerated breakdown of NO, and consequently, an impair-
ment of endothelial function (24,25). In a recently pub-
lished clinical study, Hornig et al. (26) demonstrated that
the early and late application of the radical scavenger
vitamin C, improves flow-induced, NO-mediated vasodila-
tion in forearm vessels of patients with CHF. In cell culture
experiments, shear stress was associated with an upregula-
tion of the cytosolic copper/zinc–containing superoxide
dismutase, a free radical scavenger enzyme (27). Thus, the
inactivation of NO by vascular superoxide anions or other
reactive oxygen species may be attenuated after ET.
The fact that we did not find any differences in
endothelium-independent vasodilation after training may
indicate either that NTG was administered in sufficient
excess above any reactive oxygen species or that a longer
training intervention may be necessary to influence
endothelium-independent vasodilation.
Clinical implications. In the present study, we demon-
strated that four weeks of lower-limb aerobic ET corrects
radial artery endothelial dysfunction in patients with CHF.
The finding that the beneficial effects of training are not
confined to the trained extremity indicates a systemic effect
on endothelial function. Our study implies that endothelial
dysfunction will be systemically improved as soon as a
critical muscle mass is trained at a level sufficient to increase
BP amplitude and shear stress. This message has important
implications for ongoing trials investigating the effects of
local ET in advanced stages of CHF.
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